You need to enable JavaScript to run this app.
logo
Quit Genius

Quit Genius

3.0

Quit Genius is the world's first digital clinic for treating nicotine, alcohol and opioid addictions. Built on the evidence-based principle of Medication-Assisted Treatment (MAT), Quit Genius combines virtual behavioral therapy with approved medication and connected devices to help employers tackle the high cost of addiction in the workplace while improving the lives of their employees.


Founded: 2017
Employees: 51-200
Total funding: $78.6M
Latest funding: $64M Series B on 7/19/2021
Investors: Atomico, StartUp Health, Y Combinator, Kinnevik AB, Village Global

Learn more about Quit Genius

Get the information you need straight to your inbox, no strings attached.

We've received your request.
A Nava advisor will email you soon with more information.

Coverage

Coverage area

Nationwide & Intl.

Minimum employees

2,500 employees

Medical plan types

Any medical plan type

Reviews for Quit Genius

3.0

(1 review)

Account support

3.0

Member experience

3.0

Implementation

3.0

Be the first to review Quit Genius